Long term evolutions of hard exudates after anti-VEGF therapy for diabetic macular oedema

Following anti-VEGF therapy, HEs decreased through w104, but stabilised after that, and initial differences among agents disappeared by two years. The change in HEs did not predict w260 visual outcomes.

Authors

Institutions

Publication Details

Journal
Eye
Published
2026-03-28
DOI
https://doi.org/10.1038/s41433-026-04408-1
Primary Topic
Retinal Diseases and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long term evolutions of hard exudates after anti-VEGF therapy for diabetic macular oedema

Kangyeun Pak, Changki Yoon, Srinivas R. Sadda
Eye
Retinal Diseases and Treatments
article

Long term evolutions of hard exudates after anti-VEGF therapy for diabetic macular oedema

Kangyeun Pak, Changki Yoon, Srinivas R. Sadda
article en

Abstract

Following anti-VEGF therapy, HEs decreased through w104, but stabilised after that, and initial differences among agents disappeared by two years. The change in HEs did not predict w260 visual outcomes.

Eye
University of California, Los Angeles (US), Seoul National University Hospital (KR), Doheny Eye Institute (US), Inje University Haeundae Paik Hospital (KR)
Openalex Percentile: Top 4%
Retinal Diseases and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.